Table 3 Change in symptoms compared to baseline at each time point through 12 months.

From: Association of treatment-emergent symptoms identified by patient-reported outcomes with adjuvant endocrine therapy discontinuation

Symptom Domain

3 months

N (%)

6 months

N (%)

12 months

N (%)

Physical Functiona

No change or improvement

189 (58.9)

184 (57.3)

150 (46.7)

Worsening by less than the MID

44 (13.7)

28 (8.7)

22 (6.9)

Worsening by at least the MID but less than twice the MID

28 (8.7)

26 (8.1)

19 (5.9)

Worsening by at least twice the MID but less than three times the MID

13 (4)

9 (2.8)

16 (5)

Worsening by at least three times the MID

8 (2.5)

6 (1.9)

7 (2.2)

PRO not completed

38 (11.8)

67 (20.9)

106 (33)

Endocrine Symptomsb

No change or improvement

123 (38.3)

106 (33)

79 (24.6)

Worsening by less than the MID

74 (23.1)

74 (23.1)

57 (17.8)

Worsening by at least the MID but less than twice the MID

48 (15)

40 (12.5)

42 (13.1)

Worsening by at least twice the MID but less than three times the MID

22 (6.9)

17 (5.3)

19 (5.9)

Worsening by at least three times the MID

14 (4.4)

15 (4.7)

17 (5.3)

PRO not completed

39 (12.1)

68 (21.2)

106 (33)

Sexual Problemsc

No change or improvement

201 (62.6)

187 (58.3)

114 (44.9)

Worsening by less than the MID

1 (0.3)

0 (0)

0 (0)

Worsening by at least the MID but less than twice the MID

18 (5.6)

15 (4.7)

19 (5.9)

Worsening by at least twice the MID but less than three times the MID

19 (5.9)

15 (4.7)

14 (4.4)

Worsening by at least three times the MID

38 (11.8)

31 (9.7)

33 (10.3)

PRO not completed

43 (13.4)

72 (22.4)

110 (34.3)

Depressiona

No change or improvement

192 (59.8)

175 (54.5)

139 (43.3)

Worsening by less than the MID

31 (9.7)

17 (5.3)

22 (6.9)

Worsening by at least the MID but less than twice the MID

37 (11.5)

28 (8.7)

24 (7.5)

Worsening by at least twice the MID but less than three times the MID

12 (3.7)

20 (6.2)

15 (4.7)

Worsening by at least three times the MID

8 (2.5)

10 (3.1)

12 (3.7)

PRO not completed

40 (12.5)

70 (21.8)

108 (33.6)

Anxietya

No change or improvement

180 (56.1)

170 (53)

136 (42.4)

Worsening by less than the MID

39 (12.1)

34 (10.6)

31 (9.7)

Worsening by at least the MID but less than twice the MID

29 (9)

19 (5.9)

23 (7.2)

Worsening by at least twice the MID but less than three times the MID

22 (6.9)

16 (5)

9 (2.8)

Worsening by at least three times the MID

11 (3.4)

14 (4.4)

15 (4.7)

PRO not completed

39 (12.1)

67 (20.9)

106 (33)

Sleep Disturbancea

No change or improvement

146 (45.5)

139 (43.3)

120 (37.4)

Worsening by less than the MID

49 (15.3)

40 (12.5)

34 (10.6)

Worsening by at least the MID but less than twice the MID

50 (15.6)

40 (12.5)

27 (8.4)

Worsening by at least twice the MID but less than three times the MID

17 (5.3)

18 (5.6)

18 (5.6)

Worsening by at least three times the MID

20 (6.2)

16 (5)

16 (5)

PRO not completed

38 (11.8)

67 (20.9)

105 (32.7)

Fatiguea

No change or improvement

158 (49.2)

130 (40.5)

116 (36.1)

Worsening by less than the MID

58 (18.1)

53 (16.5)

40 (12.5)

Worsening by at least the MID but less than twice the MID

33 (10.3)

44 (13.7)

38 (11.8)

Worsening by at least twice the MID but less than three times the MID

18 (5.6)

14 (4.4)

11 (3.4)

Worsening by at least three times the MID

14 (4.4)

11 (3.4)

10 (3.1)

PRO not completed

39 (12.1)

68 (21.2)

105 (32.7)

Pain Interferencea

No change or improvement

209 (65.1)

193 (60.1)

153 (47.7)

Worsening by less than the MID

22 (6.9)

17 (5.3)

16 (5)

Worsening by at least the MID but less than twice the MID

23 (7.2)

17 (5.3)

26 (8.1)

Worsening by at least twice the MID but less than three times the MID

11 (3.4)

11 (3.4)

9 (2.8)

Worsening by at least three times the MID

16 (5)

14 (4.4)

10 (3.1)

PRO not completed

39 (12.1)

68 (21.2)

106 (33)

  1. MID minimal important difference, PRO patient-reported outcome.
  2. a MID = 4 points;
  3. b MID = 5 points;
  4. c MID = 8 points.